NIH-funded research Fellowship grant

Understanding how certain brain receptors are regulated by cell adhesion molecules

Official title: Elucidating transsynaptic regulation of metabotropic glutamate receptors

Funded at University of Florida · NIH-11000253 · Data updated 2026-11-12

This study is looking at how certain brain proteins work together to keep glutamate levels balanced, which is important for thinking and movement, and it hopes to find ways to help prevent problems like epilepsy and movement disorders.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startJanuary 1, 2023
Project endDecember 31, 2025
Funding year2025
Award (this year)$74,284
NIH project number5F32NS124758-03
Project IDNIH-11000253 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with neurological conditions that involve glutamate dysregulation, such as epilepsy or movement disorders.

Less likely to help

Patients with conditions unrelated to glutamate signaling or those without neurological disorders may not benefit from this research.

What this research studies

This research investigates the interactions between metabotropic glutamate receptors and cell-adhesion molecules in the brain. It aims to understand how these interactions help regulate glutamate levels, which are crucial for cognitive and motor functions. By studying these mechanisms, the research seeks to uncover the role of these proteins in maintaining synaptic health and preventing disorders like epilepsy and movement issues. The approach includes examining the binding and stabilization of these receptors through advanced techniques.

Why it matters

Potential benefit: If successful, this research could lead to new insights into treating neurological disorders related to glutamate dysregulation.

How similar studies have gone: Previous research has shown promising results in understanding GPCR regulation, indicating that this approach has potential for success.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Ludlam, William Grant — University of Florida
  • Study coordinator: Ludlam, William Grant

Related research

Other NIH-funded projects on the same topics.

  • Mitochondrial pores and muscle loss in cancer cachexia

    A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.

    NIH research University of Florida · Gainesville, United States · NIH-11636110

  • Photobiomodulation for jaw pain from TMD

    A clinician-scientist at the University of Florida is testing a light-based therapy to help adults with temporomandibular disorder pain feel better and jaw function improve.

    NIH research University of Florida · Gainesville, United States · NIH-11635590

  • How the brain controls swallowing and airway protection

    A research team at the University of Florida is studying how brain networks control swallowing to reduce risk of choking and lung infections in people with neuromuscular diseases.

    NIH research University of Florida · Gainesville, United States · NIH-11630949

  • Donor-driven 3D organoid platform to study pancreatic cancer drug response

    A pilot project to create patient-derived, 3D organoid models of pancreatic cancer to measure how tumors from different people respond to chemotherapy.

    NIH research University of Florida · Gainesville, United States · NIH-11625599

  • RAAS inhibitors and pancreatic cancer risk in diverse adults

    A Florida-based study will look at whether commonly used blood pressure medicines (RAAS inhibitors) are linked to new cases of pancreatic cancer, especially among Black and Hispanic adults.

    NIH research University of Florida · Gainesville, United States · NIH-11625597

  • Pilot project exploring new cancer drugs for pancreatic cancer in African American patients

    A small, early-stage project tests new drug-derived compounds to treat pancreatic cancer, focusing on African American patients who are disproportionately affected.

    NIH research University of Florida · Gainesville, United States · NIH-11625594

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.